Emeritus Professor of Behavioural Pharmacology
Institute of Psychiatry, Psychology and Neuroscience
De Crespigny Park P048
SE5 8AF London
Ian Stolerman qualified in Pharmacy in 1964 and in 1969 received a PhD in pharmacology (University College, University of London). Postdoctoral experience was at the Albert Einstein College of Medicine (NY) and UCLA, under the direction of Professor Murray Jarvik; during this time he began work on nicotine that was to become the dominant theme in his research. Became a member of the UK Medical Research Council Scientific Staff in 1974 and in 1980 moved to the Institute of Psychiatry, London. Research techniques used have included a wide variety of animal models such as drug discrimination, stimulus detection (attention), intravenous self-administration, conditioned place preference, conditioned taste aversion and locomotor activity. The research aimed to test the role of nicotine in tobacco as a drug of abuse, to characterise the nature of its dependence-related behavioural effects and to relate these effects to nicotinic receptor subtypes and different neurotransmitter systems and brain regions. A parallel aim has been to develop and promote the use of drug discrimination methodology; defined major characteristics of the discriminative stimulus properties of drug mixtures; established the drug discrimination database. Served as Visiting Lecturer in the Department of Psychology, University of Maryland, College Park (1980), was a founder (1986) and first President of the European Behavioural Pharmacology Society, and subsequently President of the Society for Stimulus Properties of Drugs and of the International Society of Addiction Journal Editors; was a member of the editorial boards of several journals; was receiving editor for Neuropharmacology and British Journal of Pharmacology; Co-Editor of Drug and Alcohol Dependence (1992-2005); Editor-in-Chief of the Encyclopedia of Psychopharmacology (published 2010).